We deliver complete AI drug discovery — target to synthesis-ready candidates — not just candidate selection. Bring a target, bring candidates you've already designed, or bring a set that needs clearance. One platform, one auditable record.
You have a biological target but no computational design team. We generate a candidate library, predict each candidate's structure and complex with the target, with interface confidence, run the full selection and governance pipeline, and deliver a synthesis-ready build list to your wet-lab partner. One engagement replaces a fragmented stack of tools, spreadsheets, and judgment calls — from target to candidate, computationally, end to end.
See DECIDE, the engine behind this path ↓Your team designs the molecules. Ours scores, screens, and selects. Upload candidates from any generator — RFdiffusion, ProteinMPNN, your pipeline. We run structure confidence scoring, biosafety screening, and freedom-to-operate checks. You get back a ranked, auditable build list: which candidates to synthesize, why each made the cut, and sealed evidence for your board or funder.
See DECIDE in detail ↓You already know what you want to build. You need documentation that it is safe to synthesize and free to operate before committing budget. We deliver a standalone, auditable clearance report — biosafety and freedom-to-operate in one artifact.
See CLEAR in detail ↓We collaborate with leading research institutions for synthesis and validation. What they learn from a build list doesn't sit in a lab notebook — it comes back and sharpens the next round of design and scoring.
Ranked, auditable, sealed.
Our partner synthesizes and validates.
What comes back from the bench.
Design and scoring, sharpened for the next candidate library.
Closing the loop: this is what separates a discovery platform from a one-time screening tool — every engagement makes the next one better informed.
Not a score. A decision.
Request access